Page last updated: 2024-08-23

mefloquine and Colorectal Neoplasms

mefloquine has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, K; Li, S; Wang, J; Xu, F; Xu, X; Yang, Y1
Doki, Y; Haraguchi, N; Hata, T; Ishii, H; Koseki, J; Matsuda, C; Miyoshi, N; Mizushima, T; Mori, M; Nishida, N; Nishimura, J; Takahashi, H; Takeda, M; Yamamoto, H1

Other Studies

2 other study(ies) available for mefloquine and Colorectal Neoplasms

ArticleYear
Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells.
    Cancer science, 2018, Volume: 109, Issue:4

    Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; I-kappa B Kinase; Mefloquine; Mice; NF-kappa B; Phosphorylation; Signal Transduction

2018
Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells.
    Cancer research, 2019, 04-01, Volume: 79, Issue:7

    Topics: Animals; Antigens, CD; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Endosomes; Humans; Lysosomes; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; rab GTP-Binding Proteins; rab5 GTP-Binding Proteins; rab7 GTP-Binding Proteins

2019